J. Hense

2.5k total citations
56 papers, 589 citations indexed

About

J. Hense is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, J. Hense has authored 56 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 14 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in J. Hense's work include Palliative Care and End-of-Life Issues (13 papers), Glioma Diagnosis and Treatment (11 papers) and Childhood Cancer Survivors' Quality of Life (8 papers). J. Hense is often cited by papers focused on Palliative Care and End-of-Life Issues (13 papers), Glioma Diagnosis and Treatment (11 papers) and Childhood Cancer Survivors' Quality of Life (8 papers). J. Hense collaborates with scholars based in Germany, Austria and Italy. J. Hense's co-authors include P. Meusers, Martin Schüler, Mitra Tewes, G Brittinger, Martin Teufel, Mingo Beckmann, S. Seeber, Tassilo Moritz, Peter Bojko and Miriam Götte and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

J. Hense

51 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Hense Germany 15 231 179 122 86 80 56 589
Kenneth Wong United States 17 112 0.5× 159 0.9× 177 1.5× 44 0.5× 161 2.0× 53 829
Anca Prica Canada 14 238 1.0× 147 0.8× 63 0.5× 234 2.7× 24 0.3× 130 609
Gülten Tekuzman Türkiye 15 334 1.4× 64 0.4× 171 1.4× 143 1.7× 57 0.7× 58 737
Hüseyin Abalı Türkiye 16 240 1.0× 73 0.4× 182 1.5× 128 1.5× 55 0.7× 62 669
Burkhard Otremba Germany 11 234 1.0× 48 0.3× 133 1.1× 60 0.7× 25 0.3× 41 590
David Andorsky United States 15 555 2.4× 226 1.3× 127 1.0× 397 4.6× 82 1.0× 71 1.2k
Paul Rebattu France 17 580 2.5× 135 0.8× 440 3.6× 114 1.3× 40 0.5× 56 943
Teresa Halbsguth Germany 15 443 1.9× 85 0.5× 181 1.5× 485 5.6× 127 1.6× 25 971
Marina Djurfeldt Canada 13 457 2.0× 100 0.6× 236 1.9× 528 6.1× 40 0.5× 32 1.1k
Ronald Rosenburg Germany 8 83 0.4× 203 1.1× 57 0.5× 178 2.1× 32 0.4× 11 1.2k

Countries citing papers authored by J. Hense

Since Specialization
Citations

This map shows the geographic impact of J. Hense's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Hense with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Hense more than expected).

Fields of papers citing papers by J. Hense

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Hense. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Hense. The network helps show where J. Hense may publish in the future.

Co-authorship network of co-authors of J. Hense

This figure shows the co-authorship network connecting the top 25 collaborators of J. Hense. A scholar is included among the top collaborators of J. Hense based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Hense. J. Hense is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Neumann, Jens, et al.. (2025). The novel manualized RELIEVE-group treatment for burdened relatives of cancer patients: a feasibility study. Frontiers in Psychology. 15. 1492219–1492219.
2.
Schüler, Martin, J. Hense, Kaid Darwiche, et al.. (2024). Early Metabolic Response by PET Predicts Sensitivity to Next-Line Targeted Therapy inEGFR-Mutated Lung Cancer with Unknown Mechanism of Acquired Resistance. Journal of Nuclear Medicine. 65(6). 851–855. 3 indexed citations
3.
4.
Guberina, Nika, Christoph Pöttgen, Maja Guberina, et al.. (2023). Location of Recurrences after Trimodality Treatment for Glioblastoma with Respect to the Delivered Radiation Dose Distribution and Its Influence on Prognosis. Cancers. 15(11). 2982–2982. 1 indexed citations
5.
Stratmann, Jan, Marcel Wiesweg, Wilfried Eberhardt, et al.. (2023). Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world setting. Journal of Cancer Research and Clinical Oncology. 149(11). 9243–9252. 2 indexed citations
6.
Michel, Anna, Thiemo Florin Dinger, Alejandro N. Santos, et al.. (2022). Time interval between the diagnosis of breast cancer and brain metastases impacts prognosis after metastasis surgery. Journal of Neuro-Oncology. 159(1). 53–63. 4 indexed citations
7.
Müller, Svenja, Michael Fink, J. Hense, et al.. (2022). Palliative care outpatients in a German comprehensive cancer center—identifying indicators for early and late referral. BMC Palliative Care. 21(1). 221–221. 5 indexed citations
8.
Schweda, Adam, Martin Neukirchen, J. Hense, et al.. (2021). PARPACT – Paramedic Palliative Care Test. Der Schmerz. 36(5). 333–341. 4 indexed citations
9.
Beckmann, Mingo, Miriam Götte, Stefan Kasper, et al.. (2021). Changes in fatigue, barriers, and predictors towards physical activity in advanced cancer patients over a period of 12 months—a comparative study. Supportive Care in Cancer. 29(9). 5127–5137. 3 indexed citations
10.
Welt, Anja, Simon Bogner, Marina Arendt, et al.. (2020). Improved survival in metastatic breast cancer: results from a 20-year study involving 1033 women treated at a single comprehensive cancer center. Journal of Cancer Research and Clinical Oncology. 146(6). 1559–1566. 15 indexed citations
11.
Hense, J., et al.. (2019). Treatment Outcome in Patients with Primary or Secondary Transformed Indolent B-Cell Lymphomas. Oncology Research and Treatment. 42(11). 580–588. 3 indexed citations
12.
Neukirchen, Martin, Christoph Ostgathe, Mingo Beckmann, et al.. (2019). Knowledge and Self-Efficacy Assessment of Residents and Fellows Following Palliative Care Unit Rotation: A Pilot Study. American Journal of Hospice and Palliative Medicine®. 36(6). 492–499. 2 indexed citations
13.
Tewes, Mitra, et al.. (2018). Predictors of outpatients’ request for palliative care service at a medical oncology clinic of a German comprehensive cancer center. Supportive Care in Cancer. 26(10). 3641–3647. 16 indexed citations
14.
Deuschl, Cornelius, Julian Kirchner, Thorsten D. Poeppel, et al.. (2017). 11C–MET PET/MRI for detection of recurrent glioma. European Journal of Nuclear Medicine and Molecular Imaging. 45(4). 593–601. 57 indexed citations
15.
16.
Wittig, Andrea, et al.. (2011). Long survival of primary diffuse leptomeningeal gliomatosis following radiotherapy and temozolomide: case report and literature review. European journal of medical research. 16(9). 415–415. 17 indexed citations
17.
Schulte, Dirk Michael, Hilmar Kuehl, Jeremias Wohlschlaeger, et al.. (2011). Multivisceral systemic metastases from an intracranial anaplastic meningioma: A case report and review of literature. Clinical Neurology and Neurosurgery. 113(7). 592–595. 12 indexed citations
18.
Hilger, Ralf A., Heike Richly, M. Grubert, et al.. (2009). Pharmacokinetics of sorafenib in patients with renal impairment undergoing hemodialysis. International Journal of Clinical Pharmacology and Therapeutics. 47(1). 61–64. 31 indexed citations
19.
Hense, J.. (2007). Palliation respiratorischer Symptome. Der Urologe. 46(1). 14–20. 2 indexed citations
20.
Bojko, Peter, et al.. (2004). Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution. Annals of Hematology. 84(2). 110–114. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenneth Wong Breakdown of academic impact, for papers by Anca Prica Breakdown of academic impact, for papers by Gülten Tekuzman Breakdown of academic impact, for papers by Hüseyin Abalı Breakdown of academic impact, for papers by Burkhard Otremba Breakdown of academic impact, for papers by David Andorsky Breakdown of academic impact, for papers by Paul Rebattu Breakdown of academic impact, for papers by Teresa Halbsguth Breakdown of academic impact, for papers by Marina Djurfeldt Breakdown of academic impact, for papers by Ronald Rosenburg
Rankless by CCL
2026